(Adds details)
May 31 (Reuters) - Medtronic Plc reported a by higher sales in its cardiac and vascular unit which sell pacemakers, catheters and coronary stents among other devices.
Sales in the cardiac and vascular unit rose 5.4 percent to $2.74 billion, accounting for about 36 percent of its total sales.
The world's largest standalone medical device maker said it sees full-year 2017 adjusted earnings of $4.60 to $4.70 per share, compared to analysts' average estimate of $4.70, according to Thomson Reuters I/B/E/S.
The company earned $1.10 billion, or 78 cents per share, in the fourth quarter ended April 29, compared with a loss of $1 million, a year earlier.
On an adjusted basis, Medtronic earned $1.27 per share beating the average analysts' estimate of $1.26 per share.
Sales rose to $7.57 billion from $7.30 billion. The company said a strong dollar reduced fourth quarter revenue by $179 million.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Shounak Dasgupta) ((penumudi.amrutha@thomsonreuters.com; within U.S. +1 646 223 8780 outside U.S. +91 80 6749 4486; Reuters Messaging: penumudi.amrutha.thomsonreuters.com@reuters.net))
May 31 (Reuters) - Medtronic Plc reported a by higher sales in its cardiac and vascular unit which sell pacemakers, catheters and coronary stents among other devices.
Sales in the cardiac and vascular unit rose 5.4 percent to $2.74 billion, accounting for about 36 percent of its total sales.
The world's largest standalone medical device maker said it sees full-year 2017 adjusted earnings of $4.60 to $4.70 per share, compared to analysts' average estimate of $4.70, according to Thomson Reuters I/B/E/S.
The company earned $1.10 billion, or 78 cents per share, in the fourth quarter ended April 29, compared with a loss of $1 million, a year earlier.
On an adjusted basis, Medtronic earned $1.27 per share beating the average analysts' estimate of $1.26 per share.
Sales rose to $7.57 billion from $7.30 billion. The company said a strong dollar reduced fourth quarter revenue by $179 million.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Shounak Dasgupta) ((penumudi.amrutha@thomsonreuters.com; within U.S. +1 646 223 8780 outside U.S. +91 80 6749 4486; Reuters Messaging: penumudi.amrutha.thomsonreuters.com@reuters.net))
